Altogen is research-based biologics company focused on cell therapy and supporting investigators with their research, understanding the translational medicine as well as regenerative medicine. Altogen centers on delivering the regenerative potential of human cord tissue and blood to a laboratory environment for the ultimate mission of bringing scientific advances to a clinical setting. Human cord blood is a rich source of hematopoietic stem and progenitor cells. An increasing number of clinical trials have only scratched the surface of its potential, giving way to a burgeoning research sub-field of regenerative medicine.
To support the development of cutting-edge translational science and regenerative medicine, Altogen’s GMP and high-quality R&D compliance laboratory produces the highest quality Cord Blood Stem Cells (CBSC), Wharton’s Jelly and Hematopoietic Stem Cells (HSC) for research use. The purity, vitality and viability of cells and processes designed to meet the most rigorous applicable federal standards to ensure the highest-quality products for our clients’ research projects.